Join us Sept. 14-16 in Miami to connect with top publishing leaders
The digital media industry often hears from all constituencies but often leaves out an important one: brands. That’s despite the fact that brands, and their budgets, are what makes the whole system go.
Next week’s Digiday Brand Conference, held Sept. 19 at the W New York, will change that, with executives from brands like Citi, Puma, GE, Nissan and Jack Daniel’s detailing what excites and frustrates them about digital media, their wins and losses, and what they wish would change in the industry.
Citi’s Linda Descano and Puma’s Remi Carlioz will take the stage to discuss how the two brands use content marketing to engage their customers. You’ll be surprised how similar a financial services provider and an athletic shoe maker can be — and what they can learn from each other from their trials and tribulations.
In a market that is ridden with campaigns using similar approaches, the event will also highlight case studies, from notable brands Vitaminwater, Elizabeth Arden and Jack Daniel’s. In each instance, a member of the team will present a unique campaign that is sure to get the audience thinking about differentiation.
Of course, the day would not be complete without a session on the ROI of social media. Attendees will hear from Nissan’s Erich Marx and Deep Focus’ Ian Schafer (who are, by the way, both up for a Sammy award later that night).
For more information and to register for the event, visit www.digidaybrandconference.com.
More in Marketing
Future of Marketing Briefing: The public ad tech era is over
Gone are the days when investors got themselves in a tizzy over ad networks, demand-side platforms and supply-side platforms on their own merits.
By the numbers: Wall Street’s tough assessment of ad tech
Big Tech continues to dominate digital growth, triggering a Wall Street exodus, but are returns imminent?
CMOs are struggling to link AI visibility with sales
Brands are spending on tools that rate their visibility within LLM responses and AI search, but proving the commercial impact of GEO remedies isn’t easy.